FDA authorizes Phosphorus Diagnostics’ COVID-19 saliva test for emergency use

OraSure Technologies (OSUR +0.7%) announces that Phosphorus Diagnostics was granted an Emergency Use Authorization by the FDA allowing individuals to self-collect saliva specimens with company’s Oragene Dx (OGD-510) collection kit for the detection of SARS-CoV-2 using the Phosphorus COVID-19 RT-qPCR test.

The Phosphorus COVID-19 RT-qPCR test detects nucleic acid in the saliva of individuals who are suspected of COVID-19 infection.

https://seekingalpha.com/news/3581116-fda-authorizes-phosphorus-diagnostics-covidminus-19-saliva-test